Notoginsenoside R1 for Organs Ischemia/Reperfusion Injury: A Preclinical Systematic Review

• Egile Nagusiak: Qiang Tong (Egilea), Peng-chong Zhu (Egilea), Zhuang Zhuang (Egilea), Li-hui Deng (Egilea), Zi-hao Wang (Egilea), Hua Zeng (Egilea), Guo-qing Zheng (Egilea), Yan Wang (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2019-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Notoginsenoside R1 (NGR1) exerts pharmacological actions for a variety of diseases such as myocardial infarction, ischemic stroke, acute renal injury, and intestinal injury. Here, we conducted a preclinical systematic review of NGR1 for ischemia reperfusion (I/R) injury. Eight databases were searche...